Michael Kaufman
Angel Investor @ MAK Capital
Boston, United States
Michael Kaufman is a Series A investor at MAK Capital in Boston focused on Medical and Biotechnology. Michael is managing partner of Knowledge Based Transactions (KBT), a healthcare technology advisory firm based in Boston. KBT provides merger and acquisition, alliance, and strategic consulting services to healthcare technology firms. He was previously Executive Vice President of Eclipsys Corporation (ECLP). At Eclipsys, he was responsible forall of the company’s corporate development activity including mergers and acquisitions, alliances, product strategy, and new business development. As a key member of the executive team, he had a key role in bringing the company public, and growing the company to a billion dollar plus major player in the Healthcare Information Technology arena.Prior to Eclipsys, Michael was the CEO of SDK Healthcare Information Systems. SDK was founded in 1961 as the first company in healthcare computing. SDK provided industry leading revenue cycle systems to major hospitals across the country. In 1997, the company was one of two companies merged to form Eclipsys Corporation.He is on the national council of Washington University in St Louis and serves on the advisory board of the Health Sector Management program of the Graduate School of Management at Boston University. He serves on the board of several early stage Healthcare technology companies and venture capital firms.He holds a BA and an MBA from Boston University and an MSW in social policy and administration from Washington University in St Louis.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Michael Kaufman invests in
Stages Michael Kaufman invests in
Countries Michael Kaufman invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Biotechnology 1 (100%)
- Product Research 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| MARAbio is a biotech firm that works to detect and prevent severe forms of Autism. | $19.1M / Series A / Oct 07, 2024 |
Co-Investors
About MAK Capital
MAK Capital outperform competitors over the long term by opportunistically investing in a fundamental
MAK Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Craig Nemiroff
Managing Director
|
|||
|
Michael Kaufman
CEO
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Michael Kaufman invest in?
Michael Kaufman invests primarily in Medical, Biotechnology and Product Research startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Michael Kaufman?
Public channels for Michael Kaufman include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Michael Kaufman last invest?
The most recent investment recorded for Michael Kaufman closed in Oct 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
